Anti Hypertensive Drugs Flashcards
What is hypertension
Blood pressure is the force of circulating blood against the walls of the body’s arteries, the major blood vessels in the body. Hypertension is when the force of the blood pressure is excessive.
Most people with high blood pressure
DO NOT KNOW THEY HAVE IT.
Hypertension is diagnosed if blood pressure readings are
—— or above on —- different days.
Hypertension is diagnosed if blood pressure readings are
140-90 or above on two different days.
Hypertension is not the Most common cardiovascular dx. Tor F
F
Most common cardiovascular dx.
Hypertension is Asymptomatic in most cases. Tor F
T
If hypertension is untreated , usually lead to complications such as ———, ———, ———, ——— and ———.
Untreated, usually lead to complications such as stroke, heart failure, kidney failure, ischaemic heart dx and death.
How many people worldwide have hypertension
1.13 billion people worldwide have hypertension
Hypertension is a silent killer. Tor F
T
Epidemiology of hypertension
▪Prevalence is decreasing world wide. T or F
▪—% of adult population in the U.S. ▪More prevalent in Nigeria — - —%. ▪Affect some races and gender.T or F
▪Mainly 2 types; which are:
Epidemiology
▪Prevalence is increasing world wide. ▪18% of adult population in the U.S. ▪More prevalent in Nigeria 25- 30%. ▪Affect all races and gender.
▪Mainly 2 types
▪1. Primary (Essential) HTN
▪2. Secondary HTN – “RENVAP”.
▪1. Primary (Essential) HTN – —%,
Not idiopathic and also not associated with risk factors Tor F
▪2. Secondary HTN – list the medical conditions it’s associated with
- Primary (Essential) HTN – 90%,
idiopathic, but associated risk factors ▪2. Secondary HTN – “RENVAP”.
R- renal
E-endocrine(thyrotoxicosis,pheochromocytoma)
N-neuronal( cerebral neuropathy, NF)
V-Vascuar
A-vascular
P- pregnancy
OR
RENALS
© Renal -+ glomerulonephritis, renal artery stenosis)
© Endocrine -+ Cushing’s disease, Conn’s syndrome, pheochromocytoma, acromegaly. corticosteroids, oral contraceptive pill)
Neurogenic- raised intracranial pressure
© Aortic coarctation
© Little people - pregnancy-induced hypertension)
© Stress - trauma, white coat hypertension
Classification
ESH-ESC1
BP category Systolic. Diastolic
(mmHg). (mmHg)
-Optimal. ———. & ———
-Normal. ———. &/or ———
-High normal. ———. &/or ———
-Grade 1(mild) ———. &/or ———
-Grade 2. ———. &/or ———
(Moderate)
-Grade 3. ———. &/or ———
(Severe)
-Isolated ———. & ———
Systolic
HTN
ESH-ESC1
BP category Systolic. Diastolic
(mmHg). (mmHg)
-Optimal. <120. & <80
-Normal. 120-129. &/or 80-84
-High normal. 130-139. &/or 85-89
-Grade 1(mild) 140-159 &/or 90-99
-Grade 2. 160-179. &/or 100-109
(Moderate)
-Grade 3. >/=180. &/or >/=110
(Severe).
-Isolated >/=140. & <90
Systolic
HTN
Classification of hypertension
INC 72
BP category Systolic. Diastolic
(mmHg). (mmHg)
-Normal. ———. &/or ———
-pre-HTN. ———. or ———
-Stage 1. ——— or ———
-stage 2. ——— or. ———
BP category Systolic. Diastolic
(mmHg). (mmHg)
-Normal. <120 &/or <80
-pre-HTN. 120-139 or 80-89
-Stage 1. 140-159 or 90-99
-stage 2. >/=160 or. >/=100
Classification of HTN severity
BP category Systolic. Diastolic. Risk
(mmHg). (mmHg)
-Normal. ———. ———. ——
-pre-HTN. ———. ———. ——
-Stage 1(mild) . ———. ———. ——
-Stage 2 ———. ———. ——
(Moderate)
-Stage 3. ———. ———. ——
(Severe)
-stage 4. ———. ———. ——
(Very Severe)
Classification of HTN severity
BP category Systolic. Diastolic. Risk
(mmHg). (mmHg)
-Normal. <130 <85 None
-pre-HTN. 120-139 80-90. Slight
-Stage 1(mild) .140-159 90-99. Longterm
-Stage 2 160-179 100-109. 50% in
(Moderate). 5yrs
-Stage 3. 180-209. 110-119. 40% in
(Severe). 2yrs
-stage 4. >210. >120. Emer
(Very Severe) gency
Physiology of Blood pressure
▪BP = ———- X ——-.
▪Arterial pressure affected by:
▪– ————-
▪– ————-
▪– ————-
Physiology of Blood pressure
▪BP = Cardiac Output X Peripheral Vascular Resistance.
▪Arterial pressure affected by:
▪– the autonomic nervous system (fast)
▪– the renin-angiotensin system (hours or days) ▪– the kidneys (days or weeks)
Hypertension- Pathophysiology
▪Effective pharmacologic lowering of blood pressure prevents the damage to ———- and reduces the ——- and ——— rate.
▪In order to understand the pathophysiology of hypertensive states and, in turn, the underlying rationale of drug therapy, an appreciation of the systems normally involved in monitoring and regulating ———- is required.
▪Two factors which determine blood pressure are ———- and ———-of the vasculature.
Hypertension- Pathophysiology
▪Effective pharmacologic lowering of blood pressure prevents the damage to blood vessels and reduces the morbidity and mortality rate.
▪In order to understand the pathophysiology of hypertensive states and, in turn, the underlying rationale of drug therapy, an appreciation of the systems normally involved in monitoring and regulating blood pressure is required.
▪Two factors which determine blood pressure are cardiac out put (stroke volume x heart rate) and total peripheral resistance of the vasculature.
Antihypertensive therapies include:
Antihypertensive therapies
1.Non pharmacological therapy of hypertension
- Pharmacological therapy of hypertension.
Antihypertensive therapies
1.Non pharmacological therapy of hypertension include:
Antihypertensive therapies
1.Non pharmacological therapy of hypertension
◦ Low sodium chloride diet
◦ Weight reduction
◦ Exercise
◦ Cessation of smoking
◦ Decrease in excessive consumption of alcohol
◦ Psychological methods (relaxation, meditation …etc)
◦ Dietary decrease in saturated fats.
Classification of anti-hypertensive by
site or mechanism:
Classification of anti-hypertensive by
site or mechanism
A. Sympatholytic drug
B. Calcium channel blockers (CCB)
C. Angiotensin-converting enzyme Inhibitors(ACEI) D. Angiotensin II receptor antagonists (ARB)
E. Vasodilators
F. Diuretics
Classification of anti-hypertensive by site or mechanism
A.Class:Sympatholytic drug
Mechanism of action:——
B. Class:Calcium channel blockers (CCB)
Mechanism of action: ———
C. Class: Angiotensin-converting enzyme Inhibitors(ACEI)
Mechanism of action: ———
D. Class:Angiotensin II receptor antagonists (ARB)
Mechanism of action: ———
E. Class:Vasodilators
Mechanism of action: ———
F. Class:Diuretics
Mechanism of action:———
Classification of anti-hypertensive by site or mechanism
A.Class:Sympatholytic drug
Mechanism of action: Blockade of sympathetic activities and decrease in peripheral resistance
B. Class:Calcium channel blockers (CCB)
Mechanism of action: inhibition of calcium influx in to arterial smooth muscle cells, resulting in a decrease in peripheral resistance.
C. Class: Angiotensin-converting enzyme Inhibitors(ACEI)
Mechanism of action: inhibits angiotensin converting enzyme that hydrolyzes angiotensin I (Inactive) to angiotensin II (Active)
D. Class:Angiotensin II receptor antagonists (ARB)
Mechanism of action: Inhibit Angiotensin II receptor, resulting in a decrease in peripheral resistance
E. Class:Vasodilators
Mechanism of action: Dilate arterial and venous blood vessels, resulting in a decrease in peripheral resistance.
F. Class:Diuretics
Mechanism of action:lower blood pressure by depleting the body sodium and reducing blood volume
Classification of anti-hypertensive by site or mechanism of action
A. Sympatholytic drug
1. a) ß Adrenergic receptor antagonist (Beta blockers):
b) Cardio-selective/β1-selective blockers:
c) Non-selective β1/β2:
- a) ß Adrenergic receptor antagonist (Beta blockers): the “olol”
◦ Atenolol
◦ Metoprolol
◦ Nadolol
◦ nebivolol
• Oxprenolol
• Pindolol
• Propranolol
• Timolol
b) Cardio-selective/β1-selective blockers:
▪Acebutolol ▪Atenolol ▪Betaxolol ▪Bisoprolol
▪ Esmolol
▪ Metoprolol ▪ Nebivolol
c) Non-selective β1/β2:
▪Carvedilol ▪Labetalol ▪Nadolol ▪Penbutolol
• Pindolol
• Propranolol • Sotalol
• Timolol
Classification of anti-hypertensive by site or mechanism of action
A. Sympatholytic drug
- α Adrenergic receptor antagonist (alpha blockers):
- Mixed adrenergic antagonist:
- Centrally acting agent/ α2 receptor agonist:
5.Adrenergic neuron blockers:
Classification of anti-hypertensive by site or mechanism of action
A. Sympatholytic drug
2. α Adrenergic receptor antagonist (alpha blockers):
◦Doxazosin ◦Phentolamine ◦Indoramin ◦Phenoxybenzamine
• Prazosin. • Terazosin • Tolazoline
- Mixed adrenergic antagonist:(CBL)
◦ Carvedilol ◦ Labetalol ◦ Bucindolol - Centrally acting agent/ α2 receptor agonist:
• α –Methyldopa • Clonidine • Guanabenz
• Guanfacine • Moxonidine
5.Adrenergic neuron blockers:
• Reserpine • Guanadrel
Classification of anti-hypertensive by site or mechanism of action
B. Calcium channel blockers
1. Dihydropyridines:
2. Non-dihydropyridines:
Classification of anti-hypertensive by site or mechanism of action
B. Calcium channel blockers
the “dipine”
- Dihydropyridines:(CA 4N LLIF)
◦ Amlodipine
◦ Cilnidipine
◦ Felodipine
◦ Isradipine
◦ Lercanidipine
• Levamlodipine
• Nicardipine
• Nifedipine
• Nimodipine
• Nitrendipine - Non-dihydropyridines:
• Diltiazem
• Verapamil
Classification of anti-hypertensive by
site or mechanism of action
C. Angiotensin-converting enzyme Inhibitors(ACEI):
Classification of anti-hypertensive by
site or mechanism of action
C. Angiotensin-converting enzyme Inhibitors(ACEI): the “pril”
(B CLEF PQRsT)
◦ Captopril
◦ Enalapril
◦ Fosinopril
◦ Lisinopril
◦ Benazepril
• Perindopril
• Quinapril
• Ramipril
• Trandolapril
Classification of anti-hypertensive by
site or mechanism of action
D. Angiotensin II receptor antagonists:
Classification of anti-hypertensive by
site or mechanism of action
D. Angiotensin II receptor antagonists:(LOT VICE) “The sartans”
◦ Candesartan ◦ Eprosartan
◦ Irbesartan
◦ Losartan
• Olmesartan • Telmisartan • Valsartan
Classification of anti-hypertensive by
site or mechanism of action
E. Vasodilators
1. Arterial vasodilators:
2. venous vasodilators:
Classification of anti-hypertensive by
site or mechanism of action
E. Vasodilators
1. Arterial vasodilators:(HDM)
◦ Hydralazine ◦ Minoxidil
◦ Diazoxide
2. venous vasodilators:
• Sodium nitroprusside